NCT04726761

Brief Summary

24-hour ambulatory blood pressure monitoring (ABPM) is superior to office blood pressure (BP) for assessing cardiovascular risk. On the other hand, repeated cuff inflations during ABPM can cause discomfort and reduced quality of sleep. A high frequency of measurement during ABPM might result in erroneously high BP measurement, incorrect hypertension diagnoses, unnecessary treatment or just overtreatment with antihypertensive medication and potentially serious side effects. The purpose of this study is to investigate whether the frequency of measurements during ABPM impacts the measured BP during ABPM. Patients will be recruited from the Clinic of Hypertension at Aarhus University Hospital, Denmark. The study will be conducted as a randomized controlled crossover study. Participants will undergo two 24-hour ABPMs: One with a low frequency of measurement, 1-time per hour during the day and 1-time per hour during the night, and one with a high frequency, 3-times/hour during the day, and 2-times/hour at night. The primary endpoint will be the difference in 24-hour mean systolic BP between the high- and low frequency measurement ABPM.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
171

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 19, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 27, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

March 2, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 28, 2022

Completed
Last Updated

June 30, 2022

Status Verified

January 1, 2021

Enrollment Period

11 months

First QC Date

January 19, 2021

Last Update Submit

June 28, 2022

Conditions

Keywords

Ambulatory Blood Pressure MonitoringABPM

Outcome Measures

Primary Outcomes (1)

  • The difference in mean systolic blood pressure (SBP) between 24-hour ABPM with frequent and non-frequent measurement intervals

    The systolic blood pressure is one of the most important predictors of a patient's risk of cardiovascular disease that can be measured with ABPM.

    One week

Secondary Outcomes (3)

  • The difference in mean diastolic blood pressure (DBP) between 24-hour ABPM with frequent and non-frequent measurement intervals.

    One week

  • The self-reported pain/discomfort, interference in daily life, and disturbance of sleep during frequent and non-frequent measurement ABPM

    One week

  • The difference in average real variability (ARV), dipping status and morning surge during frequent and non-frequent measurement ABPM.

    One week

Study Arms (2)

Frequent/Non-frequent

Patients randomized to this order will first have an ABPM conducted with the frequent measuring intervals (3 times an hour during day and 2 times an hour at night) and then a few days later have another ABPM conducted with the non-frequent measuring interval (1 time an hour during all 24 hours)

Diagnostic Test: Ambulatory Blood Pressure Monitoring, frequent/non-frequent

Non-frequent/frequent

Patients randomized to this order will first have an ABPM conducted with the non-frequent measuring interval (1 time an hour during all 24 hours) and then a few days later have another ABPM conducted with the frequent measuring intervals (3 times an hour during day and 2 times an hour at night)

Diagnostic Test: Ambulatory Blood Pressure Monitoring, non-frequent/frequent

Interventions

Patient will have a Spacelabs 90217 attached. This device can automatically measure the blood pressure over 24 hours. Patients will have their blood pressure measured first with a frequent interval, and then a non-frequent interval.

Frequent/Non-frequent

Patient will have a Spacelabs 90217 attached. This device can automatically measure the blood pressure over 24 hours. Patients will have their blood pressure measured first with a non-frequent interval, and then a frequent interval.

Non-frequent/frequent

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients, either referred or existing patients, who has to undergo a 24-hour ambulatory blood pressure monitoring

You may qualify if:

  • Patients either has to be referred from primary care to the Clinic of Hypertension at Aarhus University hospital, or already being treated at the clinic. Both groups has to be scheduled for a 24-hour ambulatory blood pressure monitoring.

You may not qualify if:

  • Below 18 years of age
  • Have atrial fibrillation
  • Have routine nightshift work
  • Is pregnant
  • Is physically inable to have the cuff applied correctly (too large arm circumference)
  • Known insomnia or other sleeping disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hypertension Clinic, Aarhus University Hospital

Aarhus, 8200, Denmark

Location

MeSH Terms

Conditions

Hypertension

Interventions

Blood Pressure Monitoring, Ambulatory

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Blood Pressure DeterminationDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisMonitoring, AmbulatoryMonitoring, Physiologic

Study Officials

  • Niels Henrik Buus

    Klinisk Institut, Aarhus Universitets Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2021

First Posted

January 27, 2021

Study Start

March 2, 2021

Primary Completion

January 31, 2022

Study Completion

June 28, 2022

Last Updated

June 30, 2022

Record last verified: 2021-01

Locations